Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06797765 · ClinicalTrials.gov registry record

Optical Coherence Tomography Angiography in Neurological Disease

A clinical trial of Stroke and Intracerebral Hemorrhage, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT06797765 is a study of Stroke and Intracerebral Hemorrhage that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 50 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06797765, a study of Stroke and Intracerebral Hemorrhage, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

Optical Coherence Tomography Angiography (OCTA) is a non-invasive tool that images the neurovascular structures of the eye by using near-infrared light. Previous literature has demonstrated the potential of OCTA as a screening tool in stroke, but its utility in other neurological illness such as intracranial hemorrhage is unclear. Hence, this pilot study will gather preliminary data to support future grant applications to investigate this area more fully by recruiting patients with neurological illness and healthy controls and comparing their OCTA imaging parameters.

Interventions

  • DEVICE OCTA

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-10-20
Est. Completion 2026-10-20

What the Registry Record Tells You About NCT06797765

The ClinicalTrials.gov registry entry for NCT06797765 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which OCTA is the first listed.

NCT06797765 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06797765 about?

NCT06797765 is a clinical study titled "Optical Coherence Tomography Angiography in Neurological Disease". Optical Coherence Tomography Angiography (OCTA) is a non-invasive tool that images the neurovascular structures of the eye by using near-infrared light. Previous literature has demonstrated the potential of OCTA as a screening tool in stroke, but its utility in other neurological illness such as int...

What is the current status of trial NCT06797765?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-10-20. Estimated completion is 2026-10-20.

What conditions does trial NCT06797765 study?

This clinical trial studies the following conditions: Stroke, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Octa.

What interventions are being tested in trial NCT06797765?

The interventions under investigation include: OCTA (DEVICE).

Who is sponsoring clinical trial NCT06797765?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06797765 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.